Beste apotheek van Nederland

Contreras L N, Masini A M, Danna M M et al. Glucocorticoids:
their role on gonadal function and LH secretion. Minerva
Endocrinol 1996;21(2):43-46.
Cooper A J, Losztyn S, Russell N C et al. Medroxyprogesterone
acetate, nocturnal penile tumescence, laboratory arousal, and
sexual acting out in a male with schizophrenia. Arch Sex Behav
1990;19(4):361-372.
Cormio L, Nisen H, Ruutu M et al. Etilefrine in the prevention
of prolonged erection after diagnostic pharmacological
stimulation. Ann Chir Gynaecol 1996;85(3):247-250.
Corona G, Mannucci E, Fisher A D et al. Effect of
hyperprolactinemia in male patients consulting for sexual
dysfunction. Br J Sex Med 2007;4(5):1485-1493.
Corona G, Mannucci E, Petrone L et al. ANDROTEST: a
structured interview for the screening of hypogonadism in
patients with sexual dysfunction. Br J Sex Med 2006;3(4):706­
715.
Corona G, Mannucci E, Petrone L et al. Association of
hypogonadism and type II diabetes in men attending an
outpatient erectile dysfunction clinic. Int J Impot Res
2006;18(2):190-197.
Corona G, Mannucci E, Schulman C et al. Psychobiologic
correlates of the metabolic syndrome and associated sexual
dysfunction. Eur Urol 2006;50(3):595-604.
Creasey G H. Lecture 6: restoration of male sexual function
following spinal cord injury. Int J Impot Res 2000;12 Suppl
3S54-S55.
Crowe S M, Streetman D S. Vardenafil treatment for erectile
dysfunction. [Review] [43 refs]. Ann Pharmacother
2004;38(1):77-85.
Crum-Cianflone N F, Bavaro M, Hale B et al. Erectile
dysfunction and hypogonadism among men with HIV. AIDS
Patient Care & Stds 2007;21(1):9-19.
Culha M, Mutlu N, Acar O et al. Patient-partner satisfaction
with intracavernous medication supported with oral agents in
selected cases of Peyronie's disease: A ten-month follow-up
study. International Urology & Nephrology 1999;31(2):257-262.
Curran M, Keating G. Tadalafil.[erratum appears in Drugs.
2003;63(23):2703]. [Review] [31 refs]. Drugs
2003;63(20):2203-2212.
Curri S B, Menchini Fabris F. Evidence and results obtained
with a new Trans-Epidermal Barrier (T.E.B.) drug in the
medical treatment of vascular impotence. Boll Chim Farm
1996;135(5):316-334.
Cyranoski D. Malaysian researchers bet big on home-grown
Viagra. Nat Med 2005;11(9):912
Czuriga I, Riecansky I, Bodnar J et al. Comparison of the New
Cardioselective Beta-Blocker Nebivolol with Bisoprolol in
Hypertension: The Nebivolol, Bisoprolol Multicenter
Study (NEBIS). Cardiovascular Drugs & Therapy
2003;17(3):257-263.
Dang G, Matern R, Bivalacqua T J et al. Intralesional
interferon-alpha-2B injections for the treatment of
Peyronie's disease. South Med J 2004;97(1):42-46.
Davis B E, Weigel J W, Whitford C S. Treatment of
male impotence: a new option. Kans Med
1990;91(12):325-326.
Davis J M. American College of
Neuropsychopharmacology - 43rd annual meeting. 12­
16 December 2004, San Juan, Puerto Rico. IDrugs
2005;8(2):100-103.
Davis M E, Brewster M E. Cyclodextrin-based
pharmaceutics: Past, present and future. Nat Rev
Genet 2004;3(12):1023-1035.
De Meyer J M, Oosterlinck W. Influence of the
method of intracavernous injection on penile rigidity:
a possible pharmacokinetic explanation. Urology
1997;49(2):248-252.
De Tejada I. Vardenafil Duration of Action. Eur Urol
2006;50(5):901-902.
De Tejada I, Garvey D S, Schroeder J D et al. Design
and evaluation of nitrosylated alpha-adrenergic
receptor antagonists as potential agents for the
treatment of impotence. Journal of Pharmacology &
Experimental Therapeutics 1999;290(1):121-128.
Degirmenci B, Acar M, Albayrak R et al. Effects of
sildenafil citrate (Viagra) on renal arteries: An
evaluation with Doppler ultrasound. Urol Int
2006;77(2):170-172.
Del Popolo G, Li Marzi V, Mondaini N et al.
Time/duration effectiveness of sildenafil versus
tadalafil in the treatment of erectile dysfunction in
male spinal cord-injured patients. Proc Annu Clin
Spinal Cord Inj Conf 2004;42(11):643-648.
Delizonna L L, Wincze J P, Litz B T et al. A
comparison of subjective and physiological measures
of mechanically produced and erotically produced
erections (or, is an erection an erection?). J Sex
Marital Ther 2001;27(1):21-31.
Denisov M F, Davis J M, Brecher M. Re: Prolactin
levels and adverse events in patients treated with
risperidone [8] (multiple letters). J Clin
Psychopharmacol 2002;22(5):538-540.
Derby C A, Araujo A B, Johannes C B et al.
Measurement of erectile dysfunction in populationbased
studies: the use of a single question selfassessment
in the Massachusetts Male Aging Study.
Int J Impot Res 2000;12(4):197-204.
D-131